Hashiona is a London-based app that offers self-tracking tools and telemedicine connections to clinicians worldwide for patients with Hashimoto’s and other autoimmune thyroid disorders. The app uses patients’ data and AI to surface user-specific health insights and discover individual health patterns. Users receive personalized suggestions on lifestyle habits and supplements, and the company reports “hundreds of beta users” following a quiet January 2021 launch. Hashiona plans to offer a 12–14 week step-by-step programme aimed at achieving remission, individually tailored using medical records and lifestyle data. The product emphasizes a holistic approach to symptom control where access to endocrinologists is limited. The company raised funding to support product development, clinician access, and patient support initiatives.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2021